-
41
-
42
Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders
Published 2025-02-01Get full text
Article -
43
Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice
Published 2025-02-01“…Conclusions: This study demonstrates how a diversity of muscle patterns are currently treated in routine practice where the primary goal was related to the lower limb and highlights important issues for further debate, such as potential underdosing and the need to balance upper and lower limb priorities when devising a treatment plan. …”
Get full text
Article -
44
Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF
Published 2025-02-01“…Non-vitamin K oral anticoagulant (NOAC) was similar in both regions (∼28%), though Asian patients were more frequently underdosed. Both Asian and non-Asian patients who received NOAC at enrolment experienced lower all-cause mortality and non-haemorrhagic stroke/SE compared with patients on other treatments or none.All-cause mortality, non-cardiovascular mortality and major bleeding were less frequent in patients from Asia versus non-Asia (HR (95% CI): 0.62 (0.39 to 0.99), 0.52 (0.28 to 0.97), 0.58 (0.36 to 0.96), respectively). …”
Get full text
Article